Glutathione-S-transferase polymorphisms and risk of squamous-cell carcinoma of the head and neck

International Journal of Cancer

Volumn 84, Issue 3, 1999, Pages 220-224

  Cheng, Lie ^a   Sturgis, Erich M ^a   Eicher, Susan A ^a   Char, David ^a   Spitz, Margaret R ^a   Wei, Qingyi ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE TRANSFERASE;

ADULT; AGED; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; ENZYME POLYMORPHISM; FEMALE; GENE DOSAGE; GENOTYPE; HEAD AND NECK CARCINOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK FACTOR; SMOKING; SQUAMOUS CELL CARCINOMA; TOBACCO;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; GENOTYPE; GLUTATHIONE TRANSFERASE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 0032989466     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990621)84:3<220::AID-IJC4>3.0.CO;2-S     Document Type: Article

References (26)

1. BROUGHTON, B.C., STEINGRIMSDOTTIR, H. and LEHMANN, A.R., Five polymorphisms in the coding sequence of the xeroderma pigmentosum group D gene. Mutation Res., 362, 209-211 (1996).
2. CHENG, L., EICHER, S.A., GUO, Z., HONG, W.K., SPITZ, M.R. and WEI, Q., Reduced DNA repair capacity in head and neck cancer patients. Cancer Epidemiol. Biomarkers Prevent., 7, 465-468 (1998).
3. COSMAN, M., DE LOS SANTOS, C., FIALA, R., HINGERTY, B.E., SIGH, S.B., IBANEZ, V., MARGULIS, L.A., LIVE, D., GEACINTOV, N.E., BROYDE, S. and PETEL, D.J., Solution conformation of the major adducts between the carcinogen (+)-anti-benzo[a]pyrene diol epoxide and DNA. Proc. nat. Acad. Sci. (Wash.), 89, 1914-1918 (1992).
4. COUTELLE, C., WARD, P.J., FLEURY, B., QUATTROCCHI, P., CHAMBRIN, H., IRON, A., COUZIGOU, P. and CASSAIGNE, A., Laryngeal and oropharyngeal cancer, alcohol dehydrogenase 3 and glutathione S-transferase M1 polymorphisms. Hum. Genet., 99, 319-325 (1997).
5. DEAKIN, M. and 14 OTHERS, Glutathione S-transferase GSTT1 genotypes and susceptibility to cancer: studies of interactions with GSTM1 in lung, oral, gastric and colorectal cancers. Carcinogenesis, 17, 881-884 (1996).
6. FOULKES, W.D., BRUNET, J.S., SIEH, W., BLACK, M.J., SHENOUDA, G. and NAROD, S.A., Familial risks of squamous cell carcinoma of the head and neck: retrospective case-control study. Brit. Med. J., 313, 716-721 (1996).
7. GELBOIN, H.V., Benzo[a]pyrene metabolism, activation, and carcinogenesis: role and regulation of mixed function oxidases and related enzymes. Physiol. Rev., 60, 1107-1166 (1980).
8. HUDMON, K.S., HONN, S.E., JIANG, H., CHAMBERLAIN, R.M., XIANG, W., FERRY, G., GOSBEE, W. and SPITZ, M.R., Identifying and recruiting healthy control subjects from a managed care organization: a methodology for molecular epidemiologic case-control studies of cancer. Cancer Epidemiol. Biomarkers Prevent., 6, 565-571 (1997).
9. JAHNKE, V., MATTHIAS, C., FRYER, A. and STRANGE, R., Glutathione S-transferase and cytochrome P-450 polymorphism as risk factors for squamous cell carcinoma of the larynx. Amer. J. Surg., 172, 671-673 (1996).
10. JOURENKOVA, N., REINIKAINEN, M., BOUCHARDY, C., DAYER, P., BENHAMOU, S. and HIRVONEN, A., Larynx cancer risk in relation to glutathione S-transferase M1 and T1 genotypes and tobacco smoking. Cancer Epidemiol. Biomarkers Prevent., 7, 19-23 (1998).
11. KATOH, T., The frequency of glutathione-S-transferase M1 (GSTM1) gene deletion in patients with lung and oral cancer. Jpn. J. Ind. Health, 36, 435-439 (1994).
12. KOCH, W.M. and MCQUONE, S., Clinical and molecular aspects of squamous cell carcinoma of the head and neck in the nonsmoker and nondrinker. Curr. Opin. Oncol., 9, 257-261 (1997).
13. LAFUENTE, A., PUJOL, F., CARRETERO, P., VILLA, J.P. and CUCHI, A., Human glutathione S-transferase μ (GSTμ) deficiency as a marker for the susceptibility to bladder and larynx cancer among smokers. Cancer Lett., 68, 49-54 (1993).
14. LANDIS, S.H., MURRAY, T., BOLDEN, S. and WINGO, P.A., Cancer statistics, 1998. CA Cancer J. Clin., 48, 6-29 (1998).
15. OFFICE OF SMOKING AND HEALTH, NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION, CENTERS FOR DISEASE CONTROL AND PREVENTION, Cigarette smoking among adults-United States, 1993. Morb. Mortal. Wkly. Rep., 43, 925-930 (1994).
16. OPHUIS, M.B.O., VAN LIESHOUT, E.M.M., ROELOFS, H.M.J., PETERS, W.H.M. and MANNI, J.J., Glutathione S-transferase M1 and T1 and cytochrome P4501A1 polymorphisms in relation to the risk for benign and malignant head and neck lesions. Cancer, 82, 936-943 (1998).
17. PARKIN, D.M., PISANI, P. and FERLAY, J., Estimate of the worldwide incidence of eighteen major cancers in 1985. Int. J. Cancer, 54, 594-606 (1993).
18. PUGA, A., NEBERT, D.W., MCKINNON, R.A. and MENON, A.G., Genetic polymorphisms in human drug-metabolizing enzymes: potential uses of reverse genetics to identify genes of toxicological relevance. Crit. Rev. Toxicol., 27, 199-222 (1997).
19. REBBECK, T.R., Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol. Biomarkers Prevent., 6, 733-743 (1997).
20. RYBERG, D., SKAUG, V., HEWER, A., PHILLIPS, D.H., HARRIES, L.W., WOLF, C. R., ØGREID, D., ULVIK, A., VU, P. and HAUGEN, A., Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk. Carcinogenesis, 18, 1285-1289 (1997).
21. SCHANTZ, S.P., BYERS, R.M., GOEPFERT, H., SHALLENBERGER, R.C. and BEDDINGFIELD, N., The implication of tobacco use in the young adult with head and neck cancer. Cancer, 62, 1374-1380 (1988).
22. SHEN, M.R., JONES, I.M. and MOHRENWEISER, H., Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res., 58, 604-608 (1998).
23. SPITZ, M.R., FUEGER, J.J., BEDDINGFIELD, N.A., ANNEGERS, J.F., HSU, T.C., NEWELL, G.R. and SCHANTZ, S.P., Chromosome sensitivity to bleomycin-induced mutagenesis, an independent risk factor for upper aerodigestive tract cancers. Cancer Res., 49, 4626-4628 (1989).
24. TRIZNA, Z., CLAYMAN, G.L., SPITZ, M.R., BRIGGS, K.L. and GOEPFERT, H., Glutathione S-transferase genotypes as risk factors for head and neck cancer. Amer. J. Surg., 170, 499-501 (1995).
25. WANG, L.E., STURGIS, E.M., EICHER, S.A., SPITZ, M.R., HONG, W.K. and WEI, Q., Mutagen sensitivity to benzo[a]pyrene diol epoxide and the risk of squamous cell carcinoma of the head and neck. Clin. Cancer Res., 4, 1773-1778 (1998).
26. WEI, Q., EICHER, S., GUAN, Y., CHENG, L., XU, J., YOUNG, L., SAUNDERS, K.C., JIANG, H., HONG, W.K., SPITZ, M.R. and STROM, S.S., Reduced expression of hMLH1 and hGTBP: a risk factor for head and neck cancer. Cancer Epidemiol. Biomarkers Prevent., 7, 309-314 (1998).